Endocrine ophthalmopathy and radioiodine therapy
2006 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 45, no 8, 1046-1050 p.Article in journal (Refereed) Published
Endocrine ophthalmopathy is to some degree present in most patients with Graves' disease. In few cases, a severe form of the condition develops and in the majority of these cases, the course of the eye problems has been influenced by the treatment for thyrotoxicosis. In this regard, radioiodine therapy has been increasingly recognized as carrying a special risk. Here, the current understanding of endocrine ophthalmopathy and the risks associated with the development of severe eye disease are discussed. The results of a retrospective investigation of patients with severe eye disease in our hospital, and the experience with corticosteroid administration following radioiodine in order to reduce the risk of ophthalmopathy, are also presented.
Place, publisher, year, edition, pages
2006. Vol. 45, no 8, 1046-1050 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-124776DOI: 10.1080/02841860600760769ISI: 000242213300007PubMedID: 17118837OAI: oai:DiVA.org:uu-124776DiVA: diva2:317952